Back
ProAssurance Corp. 10K Form
Buy
62
PRA
ProAssurance Corp.
Last Price:
$24.23
Seasonality Move:
-1.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-06 | 10Q | PRA/ProAssurance Corp. Quarterly |
| 2023-11-08 | 10Q | PRA/ProAssurance Corp. Quarterly |
| 2023-08-08 | 10Q | PRA/ProAssurance Corp. Quarterly |
| 2023-05-09 | 10Q | PRA/ProAssurance Corp. Quarterly |
| 2022-11-08 | 10Q | PRA/ProAssurance Corp. Quarterly |
| 2022-08-08 | 10Q | PRA/ProAssurance Corp. Quarterly |
Receive PRA News And Ratings
See the #1 stock for the next 7 days that we like better than PRA
PRA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2B |
|---|---|
| Cash Flow: | $24M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $25.37 |
| Price / Book: | 0.96 |
Profitability
| EPS (TTM): | 0.65450 |
|---|---|
| Net Income (TTM): | $33.7M |
| Gross Margin: | $0 |
| Return on Equity: | 2.7% |
| Return on Assets: | 0.66% |
ProAssurance Corp. Earnings Forecast
Key ProAssurance Corp. Financial Ratios
-
The Gross Profit Margin over the past 34 years for PRA is 0.00%.
-
The Selling, General & Administrative Expenses for PRA have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 42.36% of Operating Income.
-
The Net Earning history of PRA is 4.58% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 18 years.
ProAssurance Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | PRA |
| CUSIP: | 74267C |
| Website: | proassurance.com |
Debt
| Debt-to-Equity Ratio: | 0.33 |
|---|---|
| Current Ratio: | 0.33 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.58 |
|---|---|
| Forward P/E Ratio: | 23.78 |
PRA Technical Analysis vs Fundamental Analysis
Buy
62
ProAssurance Corp. (PRA)
is a Buy
Is ProAssurance Corp. a Buy or a Sell?
-
ProAssurance Corp. stock is rated a BuyThe current ProAssurance Corp. [PRA] share price is $24.26. The Score for PRA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.